Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Tareq Abadl: Persistent Anti-β2GPI IgG Is Not a Coincidence – It’s Pathology
Tareq Abadl/LinkedIn
Feb 2, 2026, 16:18

Tareq Abadl: Persistent Anti-β2GPI IgG Is Not a Coincidence – It’s Pathology

Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil Hospital, shared a post on LinkedIn:

“β2 Glycoprotein I Antibodies — Made Simple

Many people hear the name β2 Glycoprotein I antibodies and get confused. Let’s break it down clearly

What is β2 Glycoprotein I?

β2 Glycoprotein I (β2GPI) is a normal plasma protein that binds to phospholipids and plays a role in regulating coagulation.

What does the test measure?

It detects autoantibodies against β2GPI, which are a core laboratory criterion for diagnosing Antiphospholipid Syndrome (APS).

IgG vs IgM — What’s the difference?

β2GPI – IgM

  • Often rises in early or transient immune responses
  • May be associated with infections, inflammation, or immune stress
  • Can be temporary and disappear on repeat testing
  • Lower diagnostic weight for APS

 β2GPI – IgG

  • Clinically more significant
  • Persistent elevation strongly supports APS diagnosis
  • More clearly associated with:
  • Thrombosis
  • Recurrent pregnancy loss
  • Placental insufficiency

Bottom line: IgG is more reliable and more dangerous than IgM in terms of complications.

Important Laboratory Points

The test must be repeated after ≥12 weeks to confirm persistence

  • Never interpret it alone
  • APS diagnosis requires a panel, including:
  • Lupus Anticoagulant (LA)
  • Anticardiolipin antibodies (aCL)
  • Anti-β2 Glycoprotein I antibodies
  • Medium to high titers are required — low positives may be clinically irrelevant

Advanced lab note (important):

  • IgG antibodies targeting Domain I of β2GPI are the most pathogenic and most strongly linked to thrombosis
  • Solid-phase assays (ELISA/CLIA) must follow international APS cut-offs, not manufacturer-only ranges

Simple analogy Anti-β2GPI antibodies are like someone sabotaging traffic control

Blood flow loses balance to congestion to clots

If IgG is present and persistent, this is not coincidence — it’s pathology.”

Tareq Abadl: Persistent Anti-β2GPI IgG Is Not a Coincidence - It’s Pathology

Find more posts  featuring Tareq Abadl on Hemostasis Today.

Anti-β2GPI Autoantibody APS Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine Tareq Abadl thrombosis β2GPI
NewsFeed